Condition
COPD III/IV
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (2)
P 4 (1)
Trial Status
Completed1
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07362173Phase 4Active Not Recruiting
Actualities in Procedural Sedation: Remimazolam
NCT07173348Not ApplicableNot Yet Recruiting
Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea
NCT06785337Phase 2Recruiting
"The Effect of Inhaled Nitroglycerin for COPD Patients
NCT06760325Not ApplicableEnrolling By InvitationPrimary
The Effect of a Tidal Model-Based Approach Applied During Home Visits on Mental Health Parameters and Hospital Admission Frequency in COPD Patients
NCT01123902Phase 2Completed
Effectiveness of a Hand-held Fan for Breathlessness
Showing all 5 trials